CROMSOURCE has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial is expected to be performed in Italy, though additional studies are planned by CROMSOURCE for other countries in Europe as well as the United States.
Download this press release
On March 1st, 2023 ClinChoice acquired CROMSOURCE, strengthening its global network and deepening its full-service capabilities. Strategically, the acquisition will expand ClinChoice’s coverage in Europe and in US to better meet its global clients’ needs in clinical development and staffing solution services. This merger also expands its data science technology offerings in many areas including decentralized clinical trials and risk-based monitoring.
